Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, marks the end of the first half of 2019 with major milestones as it continues to expand its footprint in neurology and lead the digital biomarker revolution across healthcare.

Source link

Related posts

Teaching NeuroImages: A case of Vogt-Koyanagi-Harada disease with bilateral retinal detachment


When robots commit wrongdoing, people may incorrectly assign the blame


Advancing methods for characterizing structure and functions of small nerve fibres in neuropathic conditions.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy